Even when what you call "downrampers" pointed out that SOC had increased considerably since the early days compared to the controlled 12 patients trial, that we needed a lot if luck and for the placebo cohort to die for our mortality end point to be met, that ards was a golden egg, 1 in a million chance, that MSB should never have detoured to the ARDS route and should have stuck with their core business with aGVHD, CHF, CLBP it was all ignored. You only want to listen to what you want to hear. You don't want any negativity and so when you failed results you are shocked that none of this could possibly have been forecast. You were convinced all MSB products were going to be approved.
I'm sorry you lost out but you had many chances to reassess your holding from pre odac drop to agvhd rejection each time the SP recovered a decent amount.
For me I've picked up 20,000 shares today a stab at CLBP and CHF I'm interested to see what happens. These next few weeks to months is going to be interesting and the SP is reasonable for where we are.
- Forums
- ASX - By Stock
- MSB
- Ann: Mesoblast Update on COVID-19 ARDS Trial
Ann: Mesoblast Update on COVID-19 ARDS Trial, page-624
-
- There are more pages in this discussion • 452 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.49 |
Change
0.140(10.4%) |
Mkt cap ! $1.701B |
Open | High | Low | Value | Volume |
$1.37 | $1.54 | $1.37 | $23.10M | 15.82M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 24758 | $1.49 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.49 | 73626 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10033 | 1.485 |
4 | 53700 | 1.480 |
1 | 770 | 1.475 |
3 | 62048 | 1.460 |
1 | 50000 | 1.455 |
Price($) | Vol. | No. |
---|---|---|
1.490 | 21995 | 1 |
1.505 | 24000 | 1 |
1.510 | 13666 | 2 |
1.515 | 99798 | 1 |
1.520 | 27250 | 3 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
NEWS
Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost
MSB (ASX) Chart |